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Nine new (+)-dehydroabietylimidazolium salts were synthesised and studied as chiral solvating agents for a number of different 8 
racemic aromatic and nonaromatic carboxylate salts. These cationic chiral solvating agents resolve racemic ionic analytes better 9 
than non-ionic ones. Bis(dehydroabietylimidazolium) bis(trifluoromethanesulfonimide) gave the best discrimination for the 10 
enantiomers of carboxylate salts. Its resolution behaviour was studied by an NMR titration experiment, which indicated 1:1 11 
complexation with the racemic analyte. The dehydroabietylimidazolium salts were also useful in enantiomeric excess (ee) 12 
determinations, and for the recognition of chirality of racemic aromatic and non-aromatic -substituted carboxylic acids.13 
Introduction 14 
The determination of enantiomeric purity is an important aspect of synthetic chemistry and various methods have been developed 15 
for this purpose. Compared to commonly used techniques (e.g., HPLC), the determination of enantiomeric purity by NMR 16 
spectroscopy has been less frequently used  as a tool in synthesis monitoring. Due to the development of higher field instruments, 17 
NMR spectroscopy has become more sensitive,1 and the enantiomeric excess (ee) may be determined up to a 94-99% level.2 This 18 
allows reliable, accurate and expedient ee determinations3 required particularly in pharmaceuticals development. Minimal sample 19 
preparation, ease of use and fast analyses make NMR spectroscopy an optimal tool for quick ee determinations.  20 
     The NMR spectra of enantiomers are indistinguishable as their chemical environments are identical. To differentiate the 21 
enantiomers, a diastereomeric environment is required. This can be created by using chiral auxiliary compounds such as chiral 22 
solvating agents, paramagnetic chiral shift reagents, chiral liquid crystals, or chiral derivatising agents.4,5 Chiral solvating agents 23 
are most often employed due to their ease of use. Both neutral and ionic chiral solvating agents have been developed, although the 24 
latter have gathered less attention.4,5  25 
The use of chiral solvating agents is based on the complexation between the chiral solvating agent (host) and the two enantiomers 26 
of the chiral substrate (guest), to generate two diastereomeric ‘complexes’.4,5 Complexation between a host and guest depends on 27 
interactions such as hydrogen bonding, stacking and ion-ion interactions.5 Aromatic moieties in chiral solvating agents can 28 
enable stacking but, more importantly, they can also provide shielding which increases resolution.4,6 Therefore most of the 29 
chiral solvating agents developed are aromatic and they can be used for both aromatic and non-aromatic chiral compounds.7 30 
Electronegative groups and hydrogen donor and/or acceptor groups are able to provide the needed interaction to create a host-guest 31 
complex.4,5 Bulky substituents are also useful, as they can obstruct complex formation for the other enantiomer, thus increasing the 32 
chemical shift difference.1 In the case of an ionic chiral solvating agent, the counter ion will also have an effect on the degree of 33 
resolution. Counter ions with a delocalised charge are often favoured as they have been observed to increase resolution.8 34 
     Our aim was to develop and investigate new ionic chiral solvating agents, as they have not been widely studied. The resin 35 
derivative (+)-dehydroabietylamine is known to have an enantiomeric recognition ability towards chiral carboxylic acids9 but, 36 
apart from recent work from our group,10,11 (+)-dehydroabietylamine has not been used as a chiral solvating agent. As it is readily 37 
available,  derived from renewable resources at a low cost, has a bulky structure, and contains both an aromatic moiety and an 38 
amine group that may also be converted to the cationic form, it should provide an ideal starting material for cationic chiral 39 
solvating agents. Although some cationic chiral solvating agents have been reported, their resolution ability has been scantily 40 
studied. In most cases, the developed chiral solvating agents have only been tested with one guest.12 A lack of comparison with a 41 
number of compounds hinders the establishment of the full potential of a developed chiral solvating agent in enantiomeric 42 
resolutions. The resolution ability of newly developed cationic chiral solvating agents has been more extensively investigated in a 43 
few cases only,10,13 predominantly with racemic aromatic carboxylic acids.10,12-14 The favoured test compound has been Mosher's 44 
acid (3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid), used either as such14 or in its anionic12 form. 45 
Here, ten different (+)-dehydroabietylimidazolium or (+)-dehydroabietylimidazolinium chiral solvating agents were prepared 46 
(Scheme 1). Their effectiveness as chiral discriminators was extensively investigated, along with the effect of the anion on the 47 
resolution, the effect of the aromatic functionality, and the question as to whether it is better for the guest to be neutral or anionic. 48 
The enantiomeric resolution of neutral guests by ionic chiral solvating agents has rarely been studied, and when the guest is a 49 
carboxylic acid, it has usually been converted to the anion.10-13 Mosher’s acid was used as a test compound as it enables detection 50 
by both 1H and 19F NMR spectroscopy. In order to carry out a systematic study, the best performing chiral solvating agent was 51 
  
 2 
used in the resolution of seven different carboxylate salts, to establish its applicability in resolving both aromatic and non-aromatic 52 
racemic carboxylic acids. 53 
 54 
 55 
Scheme 1. Synthesis of (+)-dehydroabietylimidazole (1a), and (+)-dehydroabietylimidazolium (1b, 2, and 4) and (+)-56 
dehydroabietylimidazolinium (3) salts.  57 
Experimental 58 
General 59 
All reagents and solvents were obtained from commercial suppliers (Sigma Aldrich) and were used without further purification 60 
unless otherwise stated. (+)-Dehydrobietylamine was purchased as 60% grade (Sigma-Aldrich) and purified by a method described 61 
in the literature15 with slight modifications (see below). Flash chromatography was performed on 40-63 mesh silica gel. 62 
Microwave syntheses were performed using the CEM Focused MicrowaveTM Synthesis System (Model Discover). Melting points 63 
were determined on a digital melting point apparatus (Büchi B 545). Optical rotations were determined on a digital polarimeter 64 
(JASCO DIP-1000) at 22 °C in trichloromethane as solvent. The exact mass  measurements were performed by high-resolution 65 
mass spectrometry (Brucker MicroTOF LC) with electrospray ionisation (ESI).  66 
Compound characterisation  67 
NMR experiments were performed using Varian UNITY INOVA 500 and Varian Mercury Plus 300 instruments at 27 °C. 1H 68 
NMR spectra were recorded with 4-16 transients, 4085-8000 Hz spectral width, and 1.9 s acquisition time at 500 MHz. 13C NMR 69 
spectra were recorded with 576-1500 transients, 20000-31446 Hz spectral width and 1.8 s acquisition time at 125 or 75 MHz. 19F 70 
NMR spectra were recorded with 16-32 transients, 19047 Hz spectral width, 5.0 s relaxation delay and 1.0 s acquisition time at 71 
470 MHz. All 2D HSQC spectra (see supporting information) were recorded using the Varian UNITY INOVA 500 instrument 72 
with 4 transients, 128-300 increments, 8000-4085 Hz spectral widths in 1H-dimension, 22955-31446 Hz spectral widths in 13C-73 
dimension, 1.0-2.0 s relaxation delays, and 0.128 s acquisition time. TMS was used as the reference compound in NMR 74 
measurements. Chemical shift scale of 19F was fixed by applying absolute, indirect referencing by calculating the frequency 75 
position for 0.0 ppm in 19F chemical shift scale from the 1H chemical shift scale. To differentiate the proton and carbon signals of 76 
aromatic and imidazolium and 2-imidazolinium structures, subscript Ar (CHAr) is used for aromatic and im (CHim) for 77 
imidazolium and 2-imidazolinium.  78 
 79 
Preparations 80 
Purification of (+)-dehydroabietylamine Crude 60 % (+)-dehydroabietylamine (42.0 g) was dissolved in toluene (70.0 cm3) and 81 
ethanoic acid (9.65 g) in toluene (30.0 cm3) was slowly added. The salt was left to crystallise in the refrigerator. The product was 82 
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collected by filtration and washed with hexane (30.0 cm3). (+)-Dehydroabietylamine ethanoate was recrystallised from methanol. 83 
(+)-Dehydroabietylamine ethanoate (21.0 g) was dissolved in hot water and 10% aqueous NaOH solution (28.0 cm3) was added. 84 
(+)-Dehydroabietylamine was extracted with diethyl ether (50.0 cm3) and the organic phase was washed with water until neutral, 85 
and then dried over anhydrous sodium sulfate. The solvent was evaporated, and the resultant (+)-dehydroabietylamine was dried 86 
under vacuum to yield a white solid; yield 37.0 g, 88.2%; m.p. 44.2 °C (lit. 44-45 °C)16; []22D +44.3480 (c = 10.0 mg/cm3, 87 
CHCl3); 1H NMR (500 MHz, CDCl3)  ppm 0.89 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.22 (d, J = 7.0 Hz, 6H, 2×CH3), 1.33 (m, 2H, 88 
CH2), 1.39 (m, 1H, CHH), 1.52 (dd, J = -11.8, 3.3 Hz, 1H, CH), 1.69 (m, 2H, CH2), 1.74 (m, 2H, CH2), 2.30 (dt, J = -13.1, 1.7 Hz, 89 
1H, CHH), 2.40 (d, J= -13.5 Hz, 1H, CHH), 2.61  (d, J = -13.5 Hz, 1H, CHH), 2.82 (sep. J = 7.0 Hz, CH), 2.88 (m, 2H, CH2), 6.89 90 
(d, J = 1.9 Hz, 1H, CHAr), 7.00 (dd, J = 8.1, 1.9 Hz, 1H, CHAr), 7.18 (d, J = 8.1 Hz, 1H, CHAr); 13C NMR (500 MHz, CDCl3)  91 
ppm 18.78 (CH2), 18.90 (CH3), 18.90 (CH2), 24.11 (CH3), 24.13 (CH3), 25.37 (CH3), 30.31 (CH2), 33.58 (CH), 35.36 (CH2), 37.36 92 
(C), 37.53 (C), 38.70 (CH2), 45.00 (CH), 53.99 (CH2), 123.96 (CHAr), 124.38 (CHAr), 126.94 (CHAr), 134.84 (CAr), 145.67 (CAr), 93 
147.63 (CAr); HRMS-ESI (m/z) calc. for C20H32N  [M + H]+ 286.2529, found 286.2540.  94 
Synthesis of 1-dehydroabietylimidazole (1a) (+)-Dehydroabietylamine (5.0 g, 17.54 mmol, 1.0 eq) was dissolved in 2-propanol 95 
(10.0 cm3) and 25% aqueous ammonium hydroxide solution (2.70 cm3, 17.54 mmol, 1.0 eq) was added.  A mixture of a 40% 96 
aqueous solution of glyoxal (2.17 cm3, 18.94 mmol, 1.08 eq) and 35% aqueous solution of formaldehyde (1.49 cm3, 18.94 mmol, 97 
1.08 eq) in 2-propanol (20.0 cm3) was added dropwise to the reaction mixture which was kept at 80 °C for 4 h and left to stir at 98 
room temperature overnight. Water (20.0 cm3) was added to the reaction mixture, which was then extracted with diethyl ether 99 
(40.0 cm3). The organic phase was washed with water until neutral and dried over anhydrous magnesium sulfate. The organic 100 
phase was filtered and the solvent evaporated; the crude product was dried under vacuum, and recrystallised from a diethyl ether-101 
pentane mixture. Yield 2.5 g, 41.7%; white solid; m.p. 107.6 °C; []22D -25.9560 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, 102 
CDCl3) ppm 1.00 (s, 3H, CH3), 1.21 (d, J = 6.92 Hz, 6H, 2×CH3), 1.23 (s, 3H, CH3), 1.28 (m, 1H, CHH), 1.33 (m, 1H, CHH), 103 
1.35 (m, 1H, CH), 1.38 (m, 1H, CHH), 1.70 (m, 2H, CH2), 1.87 (m, 2H, CH2), 2.25 (dt, J = -13.1, 3.5 Hz, 1H, CHH), 2.81 (sep. J 104 
= 6.9 Hz, CH), 2.89 (m, 1H, CHH), 2.96  (ddd, J = -16.9, 6.7, 2.4 Hz, 1H, CHH), 3.70 (d, J = -14.0 Hz, 1H, CHH), 3.86 (d, J = -105 
14.0 Hz, 1H, CHH), 6.83 (t, J = 1.1 Hz, 1H, CHim), 6.88 (d, J = 2.1 Hz, 1H, CHAr), 6.97 (dd, J = 8.3, 2.1 Hz, 1H, CHAr), 6.99 (t, J 106 
= 1.1 Hz, 1H, CHim), 7.12 (d, J = 8.3 Hz, 1H, CHAr), 7.38 (t, J = 1.1 Hz, 1H, CHim); 13C NMR (500 MHz, CDCl3)  ppm 18.59 107 
(CH2), 18.77 (CH3), 19.40 (CH2), 24.07 (CH3), 24.09 (CH3), 25.69 (CH3), 29.94 (CH2), 33.56 (CH), 36.72 (CH2), 37.68 (C), 38.08 108 
(C), 38.13 (CH2), 45.06 (CH), 58.45 (CH2), 121.12 (CHim), 124.12 (CHAr), 124.23 (CHAr), 126.97 (CHAr), 128.81 (CHim), 134.19 109 
(CAr), 138.73 (CHim), 145.90 (CAr), 146.84 (CAr); HRMS-ESI (m/z) calc. for C23H33N2 [M + H]+ 337.2638, found 337.2635. 110 
Synthesis of 1-(+)-dehydroabietylimidazolium bis{(trifluoromethyl)sulfonyl}amide) (1b). Bistriflamidic acid (80 mg, 2.97 111 
mM, 1.0 eq) was added to compound 1a (0.10 g, 2.97 mmol, 1.0 eq) in dichloromethane (0.5 cm3) at 0 °C. After stirring the 112 
reaction mixture for 1 h at room temperature, water (3.0 cm3) was added, two layers separated, and the organic phase was washed 113 
with water (3×2.0 cm3). The organic solvent was evaporated and product dried in vacuum. Yield 0.18 g, 96.8%; amorphous solid 114 
at room temperature; []22D -23.2360 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) ppm 1.05 (s, 3H, CH3), 1.21 (d, J 115 
= 7.0 Hz, 6H, 2×CH3), 1.24 (s, 3H, CH3), 1.25 (m, 1H, CHH), 1.29 (m, 1H, CH), 1.31 (m, 1H, CHH), 1.41 (dt, J = -12.6, 2.9 Hz, 116 
1H, CHH), 1.72 (m, 2H, CH2), 1.89 (m, 2H, CH2), 2.31 (dt, J = -12.7, 3.2 Hz, 1H, CHH), 2.82 (sep. J = 7.0 Hz, CH), 2.87 (m, 1H, 117 
CHH), 3.01  (ddd, J = -17.8, 8.4, 2.2 Hz, 1H, CHH), 4.06 (d, J = -14.3 Hz, 1H, CHH), 4.06 (d, J = -14.3 Hz, 1H, CHH), 6.90 (d, 118 
J= 1.9 Hz, 1H, CHAr), 6.99 (dd, J= 8.1, 1.9 Hz, 1H, CHAr), 7.13 (d, J = 8.1 Hz, 1H, CHAr), 7.14 (t, J = 1.5 Hz, 1H, CHim), 7.33 (t, J 119 
= 1.5 Hz, 1H, CHim), 8.40 (t, J = 1.5 Hz, 1H, CHim); 13C NMR (500 MHz, CDCl3)  ppm 18.22 (CH3), 18.31 (CH2), 19.32 (CH2), 120 
24.03 (CH3), 24.08 (CH3), 25.57 (CH3), 29.69 (CH2), 33.57 (CH), 36.59 (CH2), 37.76 (C), 37.97 (CH2), 38.08 (C), 45.62 (CH), 121 
60.92 (CH2), 119.82 (q, J = 320.8, CF3), 120.67 (CHim), 123.28 (CHim), 124.14 (CHAr), 124.33 (CHAr), 127.10 (CHAr), 133.90 122 
(CAr), 136.04 (CHim), 146.23 (CAr), 146.36 (CAr); HRMS-ESI (m/z) calc. for [C23H33N2]+ [M]+ 337.2638, found 337.2630, calc. for 123 
[C2F6NO4S2]- 279.9167, found 279.9177. 124 
Synthesis of 1,3-bisdehydroabietylimidazolium chloride (2a) Formaldehyde (35% aqueous solution; 0.14 cm3, 1.75 mmol, 1.0 125 
eq) was added dropwise to (+)-dehydroabietylamine (1.0 g, 3.51 mmol, 2.0 eq) in toluene (10.0 cm3) at 0 °C and the reaction 126 
mixture was allowed to warm to room temperature. A mixture of aqueous hydrochloric acid (35%; 0.16 cm3, 1.75 mmol, 1.0 eq) 127 
and 40% glyoxal (0.20 cm3, 1.75 mmol, 1.0 eq) was added dropwise to the reaction mixture at 0 °C which was allowed warm to 128 
room temperature, and then heated for 24 h at 80 °C. The solvent was removed by evaporation and the crude product dried under 129 
vacuum, purified by column chromatography (1:9 methanol:CH2Cl2), and crystallised from a CH2Cl2:EtO2CMe mixture. Yield 130 
0.73 g, 64.5%; white solid; m.p. 220.5 °C; []20D -66.4120 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3)  ppm 1.03 (s, 131 
6H, 2×CH3), 1.11 (m, 2H, 2×CHH), 1.15 (m, 2H, 2×CHH), 1.19 (s, 6H, 2×CH3), 1.21 (d, J = 6.9 Hz, 12H, 4×CH3), 1.24 (m, 2H, 132 
2×CH), 1.43 (dt, J = -12.7, 2.8 Hz, 2H, 2×CHH), 1.53 (m, 2H, 2×CHH), 1.62 (m, 2H, 2×CHH), 1.88 (m, 2H, 2×CHH), 2.05 (m, 133 
2H, 2×CHH), 2.19 (dt, J  = -13.0, 3.2 Hz, 2H, 2×CHH), 2.81 (sep. J = 6.9 Hz, 2H, 2×CH), 2.89 (m, 2H, 2×CHH), 2.99 (dd, J = -134 
17.4, 6.7 Hz, 2H, 2×CHH), 4.13 (d, J = -14.0 Hz, 2H, 2×CHH), 4.37 (d, J = -14.0 Hz, 2H, 2×CHH), 6.89 (d, J = 1.9 Hz, 2H, 135 
2×CHAr), 6.96 (dd, J = 8.2, 1.9 Hz, 2H, 2×CHAr), 7.07 (d, J = 8.2 Hz, 2H, 2×CHAr), 7.11 (s, 2H, 2×CHim), 10.78 (s, 1H, CHim); 13C 136 
NMR (500 MHz, CDCl3)  ppm 18.22 (2×CH3), 18.42 (2×CH2), 19.22 (2×CH2), 24.04 (2×CH3), 24.08 (2×CH3), 25.50 (2×CH3), 137 
29.72 (2×CH2), 33.53 (2×CH), 36.61 (2×CH2), 37.65 (2×C), 37.97 (2×CH2), 38.19 (2×C), 45.43 (2×CH), 60.50 (2×CH2), 122.75 138 
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(2×CHim), 124.03 (2×CHAr), 124.09 (2×CHAr), 126.98 (2×CHAr), 134.09 (2×CAr), 140.99 (CHim), 146.00 (2×CAr), 146.51 (2×CAr); 139 
HRMS-ESI (m/z) calc. for [C43H61N2]+ [M]+ 605.4829, found 605.4824. 140 
Synthesis of N,N'-bisdehydroabietyl-1,2-diaminoethane (+)-Dehydroabietylamine (1.0 g, 3.51 mmol, 2.0 eq), 141 
1,2-dibromoethane (0.15 cm3, 1.75 mmol, 1.0 eq) and Na2CO3 (0.18 g, 1.75 mmol, 1.0 eq) were added to a microwave tube with 142 
2-propanol. The reaction mixture was microwave irradiated (110 W, at 110 °C) for 2 h. The solvent was evaporated and the solid 143 
triturated with diethyl ether, collected by filtration, and then mixed with diethyl ether (20.0 cm3) and aqueous sodium hydroxide 144 
(2.0 M, 10.0 cm3). The organic phase was washed with water until neutral and dried over anhydrous sodium sulfate. The organic 145 
phase was filtered and the solvent evaporated. The solid product was dried under vacuum and purified by flash chromatography 146 
(1:9 MeOH:DCM CH2Cl2). Yield 0.78 g 74.3%; white solid; m.p. 63.8 °C; []22D +43.3160 (c = 10.0 mg/cm3, CHCl3); 1H NMR 147 
(500 MHz, CDCl3)  ppm 0.91 (s, 6H, 2×CH3), 1.20 (s, 6H, 2×CH3), 1.23 (d, J = 7.0 Hz, 12H, 4×CH3), 1.37 (m, 2H, 2×CHH), 148 
1.38 (m, 4H, 2×CH2), 1.57 (dd, J = -12.3, 2.7 Hz, 2H, 2×CH), 1.60 (m, 4H, 2×CH2), 1.71 (m, 2H, 2×CHH), 1.75 (m, 2H, 2×CHH), 149 
2.23 (dt, J = -12.8, 3.3 Hz, 2H, 2×CHH), 2.32 (d, J = -11.8 Hz, 2H, 2×CHH), 2.51 (d, J = -11.8 Hz, 2H, 2×CHH), 2.70 (s, 4H, 150 
2×CH2), 2.82 (sep. J = 7.0 Hz, 2H, 2×CH), 2.88 (m, 4H, 2×CH2), 6.87 (d, J = 1.7 Hz, 2H, 2×CHAr), 6.98 (dd, J = 8.1, 1.6 Hz, 2H, 151 
2×CHAr), 7.16 (d, J = 8.1 Hz, 2H, 2×CHAr); 13C NMR (500 MHz, CDCl3)  ppm 18.98 (4×CH2), 19.35 (2×CH3), 24.14 (4×CH3), 152 
25.47 (2×CH3), 30.46 (2×CH2), 33.58 (2×CH), 36.39 (2×CH2), 37.18 (2×C), 37.55 (2×C), 38.58 (2×CH2), 45.62 (2×CH), 50.02 153 
(2×CH2), 61.61 (2×CH2), 123.91 (2×CHAr), 124.41 (2×CHAr), 126.89 (2×CHAr), 134.88 (CAr), 145.54 (2×CAr), 147.64 (2×CAr); 154 
HRMS-ESI (m/z) calc. for C42H65N2 [M + H]+ 597.5142, found 597.5132. 155 
Synthesis of 1,3-bisdehydroabietyl-2-dihydroimidazolinium tetrafluoroborate (3a) A microwave tube was loaded with N,N'-156 
bisdehydroabietyl-1,2-diaminoethane (0.5 g, 0.84 mmol, 1.0 eq),  triethylorthoformate (0.14 cm3, 0.84 mmol, 1.0 eq), ammonium 157 
tetrafluoroborate (88 mg, 0.84 mmol, 1.0 eq) and 2-propanol (1.0 cm3). The reaction mixture was irradiated (140 W, at 110 °C) for 158 
40 min. The solvent was removed by evaporation and diethyl ether (5.0 cm3) was added. The mixture was then filtered and the 159 
resultant solid dried under reduced pressure followed by recrystallisation from a methanol-ethanenitrile mixture. Yield; 0.41 g, 160 
66.8%; white solid; m.p. 210.4 °C; []22D -45.1400 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) ppm 0.97 (s, 6H, 161 
2×CH3), 1.20 (s, 6H, 2×CH3), 1.21 (m, 2H, 2×CHH), 1.22 (d, J = 6.9 Hz, 12H, 4×CH3), 1.30 (m, 2H, 2×CH), 1.31 (m, 2H, 162 
2×CHH) 1.50 (dt, J = -13.1 Hz, 2H, 2×CHH), 1.63 (m, 4H, 2×CH2), 1.76 (m, 2H, 2×CHH), 1.84 (m, 2H, 2×CHH), 2.28 (dt, J = -163 
13.5, 3.3 Hz, 2H, 2×CHH), 2.79 (m, 2H, 2×CHH), 2.82 (sep. J = 6.9 Hz, 2H, 2×CH), 2.97 (m, 2H, 2×CHH), 3.40 (d, J = -14.8 Hz, 164 
2H, 2×CHH), 3.44 (d, J = -14.8 Hz, 2H, 2×CHH), 4.03 (m, 4H, 2×CH2), 6.88 (d, J = 2.0 Hz, 2H, 2×CHAr), 6.98 (dd, J = 8.2, 2.0 165 
Hz, 2H, 2×CHAr), 7.12 (d, J = 8.2 Hz, 2H, 2×CHAr), 7.91 (m, 1H, CH); 13C NMR (500 MHz, CDCl3) ppm 18.26 (2×CH2), 18.45 166 
(2×CH3), 18.67 (2×CH2), 23.81 (2×CH3), 23.87 (2×CH3), 25.28 (2×CH3), 29.54 (2×CH2), 33.32 (2×CH), 36.65 (2×CH2), 37.40 167 
(2×C), 37.91 (2×CH2), 38.21 (2×C), 45.29 (2×CH), 52.54 (2×CH2), 59.55 (2×CH2), 123.92 (2×CHAr), 123.98 (2×CHAr), 126.78 168 
(2×CHAr), 133.78 (CAr), 145.80 (2×CAr), 146.45 (2×CAr), 161.75 (CH); HRMS-ESI (m/z) calc. for [C43H63N2]+ [M]+ 607.4986, 169 
found 607.4995. 170 
Synthesis of 3-benzyl-1-dehydroabietylimidazolium bromide (4a) (+)-Dehydroabietylimidazole (0.3 g, 0.891 mmol, 1.0 eq), 171 
benzyl bromide (0.168 g, 0.117 cm3, 0.981mmol, 1.1 eq) and CHCl3 (0.3 cm3) were added to an microwave tube. The reaction 172 
mixture was irradiated (110 W, at 110 °C) for 1h. The product was quenched with diethyl ether, filtered and dried under vacuum. 173 
Yield 0.42 g, 93.7 %; white solid; m.p. 152.9 °C; []22D -27.0920 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) ppm 174 
1.07 (s, 3H, CH3), 1.22 (d, J = 6.9 Hz, 6H, 2×CH3), 1.22 (s, 3H, CH3), 1.23 (m, 1H, CH), 1.28 (m, 1H, CHH), 1.30 (m, 1H, CHH), 175 
1.48 (m, 1H, CHH), 1.71 (m, 2H, CH2), 1.89 (m, 1H, CHH), 2.27 (dt, J = -13.0 Hz, 1H, CHH), 2.62 (dd, J = -13.5, 7.6 Hz, 1H, 176 
CHH), 2.82 (sep. J = 6.9 Hz, CH), 2.82 (m, 1H, CHH), 3.01 (dt, J = -17.6, 6.3 Hz, 1H, CHH), 4.16 (d, J = -14.1 Hz, 1H, CHH), 177 
4.26 (d, J = -14.1 Hz, 1H, CHH), 5.60 (s, 2H, CH2), 6.89 (d, J = 1.2 Hz, 1H, CHAr), 6.98 (dd, J = 8.2, 1.2 Hz, 1H, CHAr), 7.11 (d, J 178 
= 8.2 Hz, 1H, CHAr), 7.15 (m, 1H, CHim), 7.21 (m, 1H, CHim), 7.34 (m, 3H, 3×CHAr), 7.46 (m, 2H, 2×CHAr), 10.75 (m, 1H, CHim); 179 
13C NMR (500 MHz, CDCl3) ppm 18.32 (CH2), 18.46 (CH3), 19.31 (CH2), 24.05 (CH3), 24.09 (CH3), 25.56 (CH3), 29.84 (CH2), 180 
33.55 (CH), 36.60 (CH2), 37.75 (C), 37.98 (CH2), 38.14 (C), 45.49 (CH), 53.50 (CH2), 60.86 (CH2), 121.09 (CHim), 123.74 181 
(CHim), 124.07 (CHAr), 124.21 (CHAr), 127.12 (CHAr), 129.15 (CHAr), 129.58 (CHAr), 129.64 (CHAr), 132.99 (CAr), 134.11 (CAr), 182 
138.78 (CHim), 146.09 (CAr), 146.47 (CAr); HRMS-ESI (m/z) calc. for [C30H39N2]+ [M]+ 427.3108, found 427.3118. 183 
 184 
Synthesis of guests  185 
N-Acetylation of phenylalanine was performed according to literature.17 Preparation of tetrabutylammonium salts of acids was 186 
performed by adding tetrabutylammonium hydroxide (1.0 M in methanol, 1.0 eq) to the racemic acid (1.0 eq) in methanol. After 187 
stirring for 3 h, the solvent was removed by evaporation and the product was dried in vacuum.  188 
 189 
General procedure for anion exchange  190 
Anion exchange reactions were performed according to literature.14a Li[NTf2] or ammonium tetrafluoroborate solution (1.0 M, 1.0 191 
eq) was added to the chiral solvating agent (1.0 eq, in dichloromethane) at room temperature and stirred for 1 h. The phases were 192 
separated by gravity and the organic phase was washed with water (3×10 cm3). The organic phase was concentrated and dried 193 
under vacuum.  194 
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 195 
1,3-Bisdehydroabietylimidazolium tetrafluoroborate (2b) Yield 0.21 g 94.2 %; white solid; m.p. 186.9 °C (recryst. from 196 
CH2Cl2:EtOCOMe); []20D -67.5760 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) /ppm 0.99 (s, 6H, 2×CH3), 1.03 (m, 197 
2H, 2×CHH), 1.10 (m, 2H, 2×CHH), 1.14 (m, 2H, 2×CH), 1.18 (s, 6H, 2×CH3), 1.21 (d, J = 7.0 Hz, 12H, 4×CH3), 1.35 (dt, J = -198 
12.6, 3.2 Hz, 2H, 2×CHH), 1.46 (m, 2H, 2×CHH), 1.60 (d, J = -13.6, 3.2 Hz, 2H, 2×CHH), 1.84 (m, 2H, 2×CHH), 1.98 (m, 2H, 199 
2×CHH), 2.14 (dt, J = -13.1, 3.6 Hz, 2H, 2×CHH), 2.82 (sep. J = 7.0 Hz, 2H, 2×CH), 2.86 (m, 2H, 2×CHH), 2.98 (dd, J = -17.5, 200 
6.7 Hz, 2H, 2×CHH), 4.09 (d, J = -13.2 Hz, 2H, 2×CHH), 4.16 (d, J = -13.2 Hz, 2H, 2×CHH), 6.90 (d, J = 1.9 Hz, 2H, 2×CHAr), 201 
6.97 (dd, J = 8.2, 1.9 Hz, 2H, 2×CHAr), 7.06 (d, J = 8.2 Hz, 2H, 2×CHAr), 7.10 (d, J = 1.6 Hz, 2H, 2×CHim), 9.20 (s, 1H, CHim); 202 
13C NMR (500 MHz, CDCl3) /ppm 18.21 (2×CH3), 18.35 (2×CH2), 18.99 (2×CH2), 24.06 (2×CH3), 24.09 (2×CH3), 25.51 203 
(2×CH3), 29.64 (2×CH2), 33.54 (2×CH), 36.38 (2×CH2), 37.61 (2×C), 37.95 (2×CH2), 38.06 (2×C), 45.29 (2×CH), 60.27 204 
(2×CH2), 123.12 (2×CHim), 124.06 (4×CHAr), 126.96 (2×CHAr), 134.10 (2×CAr), 139.70 (CHim), 145.95 (2×CAr), 146.53 (2×CAr); 205 
HRMS-ESI (m/z) calc. for [C43H61N2]+ [M]+ 605.4829, found 605.4837. 206 
1,3-Bisdehydroabietylimidazolium bis{(trifluoromethyl)sulfonyl}amide)  (2c) Yield 0.25 g; 92.6 %; 207 
white solid; m.p. 199.0 °C (recryst. from CH2Cl2:pentane); []22D -31.8200 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, 208 
CDCl3) /ppm 0.99 (s, 6H, 2×CH3), 1.04 (m, 2H, 2×CHH), 1.05 (m, 2H, 2×CHH), 1.16 (m, 2H, 2×CH), 1.19 (s, 6H, 2×CH3), 1.21 209 
(d, J = 6.9 Hz, 12H, 4×CH3), 1.36 (dt, J = -12.3 Hz, 2H, 2×CHH), 1.49 (m, 2H, 2×CHH), 1.63 (m, 2H, 2×CHH), 1.90 (m, 4H, 210 
2×CH2), 2.17 (dt, J = -12.8, 2.3 Hz, 2H, 2×CHH), 2.82 (sep. J = 6.9 Hz, 2H, 2×CH), 2.84 (m, 2H, 2×CHH), 3.01 (ddd, J = -17.3, 211 
6.0, 1.7 Hz, 2H, 2×CHH), 4.09 (d, J = -13.9 Hz, 2H, 2×CHH), 4.16 (d, J = -13.9 Hz, 2H, 2×CHH), 6.89 (d, J = 1.8 Hz, 2H, 212 
2×CHAr), 6.97 (dd, J = 8.1, 1.8 Hz, 2H, 2×CHAr), 7.06 (d, J = 8.1 Hz, 2H, 2×CHAr), 7.10 (s, 2H, 2×CHim), 8.62 (s, 1H, CHim); 13C 213 
NMR (500 MHz, CDCl3) /ppm 17.92 (2×CH2), 18.11 (2×CH3), 18.81 (2×CH2), 23.83 (2×CH3), 23.86 (2×CH3), 25.26 (2×CH3), 214 
29.32 (2×CH2), 33.33 (2×CH), 36.30 (2×CH2), 37.41 (2×C), 37.69 (2×CH2), 37.94 (2×C), 44.98 (2×CH), 60.45 (2×CH2), 119.95 215 
(q, J = 321.0, CF3), 123.22 (2×CHim), 123.86 (2×CHAr), 123.97 (2×CHAr), 126.76 (2×CHAr), 133.59 (2×CAr), 138.00 (CHim), 216 
145.92 (2×CAr), 146.10 (2×CAr); HRMS-ESI (m/z) calc. for [C43H61N2]+ [M]+ 605.4829, found 605.4814, calc. for [C2F6NO4S2]- 217 
279.9167, found 279.9160. 218 
1,3-Bisdehydroabietyl-2-dihydroimidazolinium bis{(trifluoromethyl)sulfonyl}amide) (3b) Yield 0.45 g; 82.7%; white solid; 219 
m.p. 88.8 °C; []22D -31.8520 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) /ppm 0.978 (s, 6H, 2×CH3), 1.17 (m, 2H, 220 
2×CHH), 1.21 (s, 6H, 2×CH3), 1.22 (d, J = 6.9 Hz, 12H, 4×CH3), 1.29 (m, 2H, 2×CHH), 1.30 (m, 2H, 2×CH), 1.47 (dt, J = -12.3, 221 
3.0 Hz, 2H, 2×CHH), 1.62 (m, 4H, 2×CH2), 1.75 (m, 2H, 2×CHH), 1.84 (m, 2H, 2×CHH), 2.29 (dt, J = -13.2, 3.2 Hz, 2H, 222 
2×CHH), 2.78 (m, 2H, 2×CHH), 2.82 (sep. J = 6.9 Hz, 2H, 2×CH), 2.99 (dd, J = -17.1, 7.0 Hz, 2H, 2×CHH), 3.35 (d, J = -14.8 223 
Hz, 2H, 2×CHH), 3.44 (d, J = -14.8 Hz, 2H, 2×CHH), 4.03 (m, 4H, 2×CH2), 6.89 (d, J = 1.7 Hz, 2H, 2×CHAr), 6.99 (dd, J = 8.3, 224 
1.7 Hz, 2H, 2×CHAr), 7.12 (d, J = 8.3 Hz, 2H, 2×CHAr), 7.75 (m, 1H, CH); 13C NMR (500 MHz, CDCl3) /ppm 18.43 (2×CH2), 225 
18.65 (2×CH3), 18.96 (2×CH2), 24.06 (2×CH3), 24.12 (2×CH3), 25.51 (2×CH3), 29.70 (2×CH2), 33.58 (2×CH), 37.05 (2×CH2), 226 
37.65 (2×C), 38.14 (2×CH2), 38.56 (2×C), 45.54 (2×CH), 52.78 (2×CH2), 59.89 (2×CH2), 119.96 (q, J = 320.6, CF3),  124.16 227 
(2×CHAr), 124.31 (2×CHAr), 127.03 (2×CHAr), 133.87 (CAr), 146.16 (2×CAr), 146.56 (2×CAr), 161.37 (CH); HRMS-ESI (m/z) calc. 228 
for [C43H63N2]+ [M]+ 607.4986, found 607.4967, calc. for [C2F6NO4S2]- 279.9167, found 279.9157. 229 
3-Benzyl-1-dehydroabietylimidazolium tetrafluoroborate (4b) Yield 0.099 g 97.5%; white solid; m.p. 113.4 °C; []22D -230 
29.9880 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3)  ppm 1.01 (s, 3H, CH3), 1.19 (m, 1H, CH), 1.20 (s, 3H, CH3), 231 
1.22 (d, J = 6.8 Hz, 6H, 2×CH3), 1.23 (m, 1H, CHH), 1.28 (m, 1H, CHH), 1.40 (dt, J = -12.5 Hz, 1H, CHH), 1.68 (m, 2H, CH2), 232 
1.87 (m, 2H, CH2), 2.26 (dt, J = -13.4 Hz, 1H, CHH), 2.74 (m, 1H, CHH), 2.82 (sep. J = 6.8 Hz, 1H, CH), 2.96 (dd, J = -13.5, 6.1 233 
Hz, 1H, CHH), 4.04 (d, J = -14.3 Hz, 1H, CHH), 4.11 (d, J = -14.3 Hz, 1H, CHH), 5.36 (s, 2H, CH2), 6.88 (d, J = 1.8 Hz, 1H, 234 
CHAr), 6.98 (dd, J = 8.1, 1.8 Hz, 1H, CHAr), 7.11 (d, J = 8.1 Hz, 1H, CHAr), 7.15 (m, 1H, CHim), 7.18 (m, 1H, CHim), 7.33 (m, 3H, 235 
3×CHAr), 7.38 (m, 2H, 2×CHAr), 9.07 (m, 1H, CHim); 13C NMR (500 MHz, CDCl3) /ppm 18.17 (CH3), 18.34 (CH2), 19.12 (CH2), 236 
24.08 (CH3), 24.12 (CH3), 25.57 (CH3), 29.75 (CH2), 33.58 (CH), 36.38 (CH2), 37.74 (C), 37.97 (C), 38.00 (CH2), 45.62 (CH), 237 
53.60 (CH2), 61.00 (CH2), 121.50 (CHim), 124.11 (CHim), 124.22 (CHAr), 124.26 (CHAr), 127.12 (CHAr), 129.08 (CHAr), 129.63 238 
(CHAr), 129.66 (CHAr), 132.92 (CAr), 134.11 (CAr), 137.43 (CHim), 146.07 (CAr), 146.52 (CAr); HRMS-ESI (m/z) calc. for 239 
[C30H39N2]+ [M]+ 427.3108, found 427.3118. 240 
3-Benzyl-1-dehydroabietylimidazolium bis{(trifluoromethyl)sulfonyl}amide) (4c) Yield 0.13 g 92.7%; amorphous solid at 241 
room temperature; []22D -25.3600 (c = 10.0 mg/cm3, CHCl3); 1H NMR (500 MHz, CDCl3) /ppm 1.02 (s, 3H, CH3), 1.18 (m, 1H, 242 
CHH), 1.19 (m, 1H, CH), 1.22 (d, J = 6.9 Hz, 6H, 2×CH3), 1.22 (s, 3H, CH3), 1.29 (m, 1H, CHH), 1.41 (m, 1H, CHH), 1.71 (m, 243 
2H, CH2), 1.87 (m, 2H, CH2), 2.29 (dt, J = -12.4 Hz, 1H, CHH), 2.73 (m, 1H, CHH), 2.82 (sep. J = 6.9 Hz, 1H, CH), 2.96 (dt, 244 
J = 17.1, 3.7 Hz, 1H, CHH), 4.06 (d, J = -14.1 Hz, 1H, CHH), 4.10 (d, J = -14.1 Hz, 1H, CHH), 5.34 (s, 2H, CH2), 6.88 (d, J = 1.6 245 
Hz, 1H, CHAr), 6.99 (dd, J = 8.3, 1.6 Hz, 1H, CHAr), 7.12 (d, J = 8.3 Hz, 1H, CHAr), 7.14 (m, 2H, 2×CHim), 7.24 (m, 1H, CHAr), 246 
7.32 (m, 2H, 2×CHAr), 7.37 (m, 2H, 2×CHAr), 8.80 (m, 1H, CHim); 13C NMR (300 MHz, CDCl3) /ppm 18.21 (CH3), 18.30 (CH2), 247 
19.14 (CH2), 24.06 (CH3), 24.10 (CH3), 25.58 (CH3), 29.68 (CH2), 33.58 (CH), 36.52 (CH2), 37.77 (C), 37.99 (C), 38.07 (CH2), 248 
45.46 (CH), 53.92 (CH2), 61.12 (CH2), 119.96 (q, J = 320.6, CF3),  121.45 (CHim), 124.11 (CHim), 124.22 (CHAr), 124.31 (CHAr), 249 
127.14 (CHAr), 129.00 (CHAr), 129.82 (CHAr), 129.99 (CHAr), 132.16 (CAr),  133.93 (CAr), 137.16 (CHim), 146.22 (CAr), 146.38 250 
(CAr); HRMS-ESI (m/z) calc. for [C30H39N2]+ [M]+ 427.3108, found 427.3122; calc. for [C2F6NO4S2]- 279.9167, found 279.9167. 251 
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Results and discussion 252 
The syntheses of (+)-1-dehydroabietylimidazole (1a) and the nine derived imidazolium salts (1b-4c) were performed as shown in 253 
Scheme 1. To obtain 1a, (+)-dehydroabietylamine was treated with aqueous NH3, glyoxal and aqueous formaldehyde in 254 
2-propanol at 80 °C (41%). The salt 1b was formed (96%) from 1a by reaction with HNTf2 in CH2Cl2 at 0 °C. Compound 2a was 255 
obtained from (+)-dehydroabietylamine, glyoxal, aqueous formaldehyde and aqueous hydrochloric acid (64%) in toluene. 3a was 256 
prepared via N,N'-bisdehydroabietyl-1,2-diaminoethane, in a one-pot reaction from (+)-dehydroabietylamine, 1,2-dibromoethane 257 
and Na2CO3 in 2-propanol with microwave heating (74%), followed by the addition of CH(OEt)3 and [NH4][BF4] in 2-propanol 258 
(66%). For improved shielding ability, 1a was quaternised with benzyl bromide under microwave irradiation to give 4a. It is 259 
known that more delocalised and bulky anions generally enhance binding between the cationic chiral solvating agent and (ionic or 260 
molecular) chiral substrate due to weaker binding between the cation and anion of chiral solvating agent.8 To tune the binding 261 
properties of 2a, 3a and 4a, anion exchange was performed with [NH4][BF4] and Li[NTf2] to obtain 2b-c, 3b and 4b-c in high 262 
yield. The delocalisation and increased size of the anion also affect the physical properties of the ionic chiral solvating agents.8 For 263 
instance, the melting points of 4a, 4b and 4c decrease when the bulkiness and delocalisation of anion increase (m.p. of Br > [BF4] 264 
> [NTf2]). 265 
     The chiral discrimination of racemic carboxylic acids and their respective carboxylate anions by (+)-1-dehydroabietylimidazole 266 
(1a) and its imidazolium salt derivatives (1b-4c) was examined with Mosher’s acid [5; F3CC(OCH3)(Ph)COOH] and its 267 
tetrabutylammonium ([N4 4 4 4]+) salt (6). The effect of the concentration of the chiral solvating agent was also investigated, since it 268 
is known that higher concentrations generally enhance the enantiomeric resolution between R and S enantiomers ().4,5 Since 269 
polar solvents can dissolve salts, and protic solvents may interfere in hydrogen bond formation,13a CDCl3 was chosen as a solvent 270 
for the NMR studies, performed by dissolving the chiral solvating agent (1.0 or 2.0 eq) in a stock solution containing 5 or 6 (0.5 271 
cm3; 1.0 eq, 22.0 mM). According to the results obtained from the NMR experiments (Table 1 and Fig. 1), the chiral solvating 272 
agents 1b-4c resolved the enantiomers of 6 very efficiently (11.4-49.9 Hz). The best results were obtained with 2c (0.11 ppm, 49.8 273 
Hz). Also the enantiomers of 5 were resolved, but with a  less than that with 6. Only 1a gave notably better discrimination for 5 274 
(19.3 Hz) compared to 1b-4c (0.88-7.0 Hz). This indicates that resolution using 1b-4c is highly dependent on the ionic nature of 275 
the guest and vice versa in the case of 5. Although ionic hosts (1b-3b and 4c) were able to discriminate 5, the neutral 1a failed to 276 
discriminate 6, making the ionic chiral solvating agents more versatile than a neutral one as the former also discriminate neutral 277 
species. For 6 and 5,  was found to be larger in the 19F NMR spectra than in the 1H NMR spectra. The ionic 1b-4c gave larger 278 
resolutions in 1H NMR spectra in the case of 5 compared to 6. This may be due to a different host-guest complex structure formed 279 
between the neutral guest and the ionic host, compared to situation when both are ionic. The increase of chiral solvating agent 280 
concentration to 2.0 eq. did not cause a significant increase in (~ 0.0-8.0 Hz). Also, in some cases (1b, 2c, 3b and 4c), the 281 
resolution was decreased due to an increased host concentration.  282 
 283 
Table 1. The 1H and 19F NMR chemical shift differences () between the R and S enantiomers of racemic Mosher’s acid (5) and 284 
its tetrabutylammonium salt (6) in the presence of various (+)-dehydroabietylimidazole chiral solvating agents (500 MHz) in 285 
CDCl3 at 27 C.  286 
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 Host: Guest 
5: ppm; (Hz) 6: ppm; (Hz) 
1H (OCH3) 19F (CF3) 1H (OCH3) 19F (CF3) 
1a 1:1 0.0092 (4.6) 0.031 (14.8) 0.000 0.000 2:1 0.011 (5.7) 0.041 (19.3) 0.000 0.000 
1b 1:1 0.002 (0.99) 0.000 0.0044 (2.2) 0.024 (11.4) 2:1 0.000 0.000 0.0042 (2.1) 0.026 (12.2) 
2a 1:1 0.0056 (2.8) 0.000 0.000 0.074 (35.0) 2:1 0.0091 (4.5) 0.000 0.000 0.080 (37.7) 
2b 1:1 0.0071 (3.5) 0.000 0.000 0.092 (43.5) 2:1 0.0099 (5.0) 0.000 0.000 0.102 (47.9) 
2c 1:1 0.002 (1.0) 0.000 0.0029 (1.5) 0.110 (49.8) 2:1 0.000 0.000 0.0061 (3.0) 0.110 (49.9) 
3a 1:1 0.000 0.007 (3.3) 0.000 0.060 (28.1) 2:1 0.000 0.015 (7.0) 0.000 0.077 (36.4) 
3b 1:1 0.0019 (1.0) 0.000 0.000 0.065 (30.6) 2:1 0.000 0.000 0.000 0.074 (34.7) 
4a 1:1 0.000 0.000 0.000 0.028 (13.4) 2:1 0.000 0.000 0.000 0.033 (15.7) 
4b 1:1 0.000 0.000 0.000 0.034 (15.7) 2:1 0.000 0.000 0.000 0.036 (17.0) 
4c 1:1 0.0017 (0.8) 0.000 0.000 0.034 (15.8) 2:1 0.000 0.000 0.000 0.032 (15.3) 
 287 
Figure 1. NMR spectra [1H (OCH3) and 19F (CF3)]  of 5 (A) and 6 (B) from the resolution of enantiomers with chiral solvating 288 
agents 1a-4c in 1:1 and 2:1 host:guest ratio. 289 
 290 
To determine which features affect the resolution of 5 and 6 by an ionic host (1b-4c), the effect of the structure of the cation 291 
and its counter anion were examined. The discrimination of enantiomers of 6 was enhanced by a bulky chiral substituent on the 292 
imidazolium N-3, an aromatic ionic unit and an anion with a more delocalised charge ([NTf2]- vs. Cl-). In the case of 5, resolution 293 
was enhanced by a bulky substituent at the N-3 site, a non-aromatic ionic unit and an anion with a more localised charge (Cl- vs. 294 
[BF4]-). For example, 1b, lacking a substituent at N-3, resolves the enantiomers of 6 less efficiently than 4c, which has a benzyl 295 
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group as the N-3 substituent. This indicates that the presence and nature of an imidazolium N-3 substituent is important for the 296 
resolution. When comparing 4a-c with 3a,b and 2a-c, where the imidazolium nucleus carries two (+)-dehydroabietyl groups, the 297 
discrimination is distinctly improved. An additional contribution to binding comes from hydrophobic and - stacking effects due 298 
to the substituents on the imidazolium unit.  This can be seen from the simplified models in Figure 2, illustrating a tentative 299 
complex structure. On comparing 3a,b and 2a-c, it is clearly seen that the aromaticity of the ionic centre has a beneficial influence 300 
on  (e.g. 2c vs 3b). Similar behaviour was noted with 5, and also in this case a bulky side chain at N-3 enhanced the resolution. 301 
The non-aromatic ionic centre (3a, 7.0 Hz) was noted to give a better resolution for 5 than for an aromatic one (2a-2c, 1.0-5.0 Hz).  302 
No explicit counter anion effects on the discrimination of molecular guests could be seen. In a 1:1 stoichiometry, [NTf2]- (2c, 303 
3b and 4c) gave the best resolution, as non-hydrogen-bonding anions (such as [NTf2]-) allow bonding between the host and the 304 
carboxylate to occur more efficiently due to its ‘loose’ association with the host cation. However, when the concentration was 305 
increased, [BF4]- gave slightly better results in the case of 3a and 4a. This phenomenon may be due to aggregation between the 306 
host and guest due to the increased concentration of host. In the case of 5, the effect of a counter anion was also noted, although in 307 
this case the delocalisation of charge in the anion did not seem to increase resolution. An anion with a more localised charge 308 
favoured resolution, and among those the size of anion (Cl- vs. [BF4]-) seemed to play a crucial role. 309 
     As 2c gave the best resolution (49.9 Hz), its enantiomeric discrimination power was further investigated by titration to find the 310 
optimum conditions for complexation. It is important to establish the structure of the complex in order to evaluate how much chiral 311 
solvating agent will be needed for optimal resolution. It also helps to evaluate if it is practical to increase the amount of host over 312 
the stoichiometric amount.  A guest solution of 6 (0.5 cm3, 2.0 mM) was measured into an NMR tube and titrated with 0.5 mm3 313 
doses of a host solution of 2c (46.6 mM). Figures 3A and 4 show the chemical shifts of S and R enantiomers as a function of host 314 
concentration.  Also, the change in the chemical shifts of enantiomers was determined (Fig. 3B) from the titration experiment. The 315 
 was not large enough in 1H NMR spectra (Fig. 4) for a reliable indication of complexation and only data from 19F NMR spectra 316 
were used. The  change between S and R enantiomers as a function of host concentration (Fig 3C) suggest that maximal 317 
resolution is obtained when the concentrations of host and guest are the same (2.0 mM, 1.0 eq), corresponding to a 1:1 318 
complexation. Also a Job’s plot18 based on data obtained from a titration experiment (Fig. 3D) confirmed the 1:1 complex 319 
stoichiometry.  320 
Figure 2. A model illustrating how the cation of 2c may interact with (left) a carboxylate anion and (right) Mosher’s carboxylate. 321 
Hydrogen atoms have been omitted for clarity. 322 
 323 
 324 
Figure 3. (A) The chemical shifts of S (+) and R () enantiomers of 6 (c = 2.0 mM); (B) the change of chemical shift of R and S 325 
enantiomers of 6; (C)  between R and S enantiomers of 6 as a function of concentration of 2c; (D) Job’s plot ([H] = the 326 
concentration of host, [G] = the concentration of guest). 327 
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Figure 4. The change of chemical shift of R and S enantiomers of 6 in (A) the 1H NMR spectra, and (B) the 19F NMR spectra. 330 
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   332 
Figure 5. Correlation between theoretical and practical ee% values of enantiomerically enriched samples of 6 (2c used as chiral 333 
solvating agent), by 19F NMR spectroscopy (470 MHz, CDCl3, 27 °C). Measured values are based on the peak areas from line 334 
fitting of the CF3 peak. 335 
 336 
The applicability of 2c in ee measurements by NMR spectroscopy was investigated employing a solution of racemic 6 and 337 
enantiomerically pure S-6 (2.0 mM). Mixtures of enantiomerically enriched samples were prepared in an NMR tube (0.5 cm3, 1.0 338 
eq.) and 2c (22.5 mm3, 46.6 mM, 1.0 eq.) was added. The determined ee% values are in line with the expected values (Fig. 5), 339 
showing that 2c can be reliably used in ee determinations. 340 
To obtain more information about the resolution behaviour of 2c, its ability to discriminate enantiomers of various ‐substituted 341 
racemic carboxylic acids was studied. Acids were converted to their tetrabutylammonium salts, as 2c showed better resolution 342 
towards  ionic species, due to stronger  interactions through  ionic and hydrogen bonding. The experiments were performed by 343 
adding a solution of 2c (46.6 mM, 22.5 cm3, 1.0 eq.) to a solution of the guest (2.0 mM, 0.5 cm3, 1.0 eq.). The results indicate 344 
(Table 2) that 2c can resolve both aromatic and non‐aromatic ‐substituted carboxylic acids. The best resolution was obtained 345 
with 11 but no essential differences between  the   values of 7‐10, 12  and 13 were detected. This  is  in contrast  to previous 346 
study7a  suggesting  that  the  presence  of  an  aromatic  ring  (in  the  carboxylic  acid)  is  necessary  for  good  signal  separation.  In 347 
addition, 2c not only resolved the proton at  the chiral centre of 7, but also the prochiral CH2 and  isopropyl groups. Such  long 348 
range effects are rare since usually only the nuclei close to the chiral centre and the nuclei adjacent to the site of association of 349 
the chiral reagent can be resolved.1 The long range effect may indicate the asymmetric shape of the pseudo‐cavity present in the 350 
host (Fig. 2). According to the results, 2c efficiently resolves chiral carboxylic acids with a large polar group at the ‐position (e.g. 351 
11) or those with a crowded ‐position (e.g. 6). Although the peaks of 7‐10, 12 and 13 were not properly baseline resolved ( 352 
2.3‐4.8 Hz),  the determinations of  ee could  still  be  feasible with  special  techniques. For  instance,  the  recently published pure 353 
shift experiments,19,20 or  J‐resolved21, RES‐TOCSY22,10c and  1H homonuclear decoupling experiment  (HOMODEC)23,24  techniques 354 
can be used for ee determinations  in cases where the baseline resolution  is  insufficient for  integration  in the 1H NMR spectra 355 
(see supporting information). In addition we inspected the possible enantiomeric resolution of three carboxylic acids (7, 11, 12) 356 
by using HSQC (2.0 mmol solution). Only  in  the case of 11  could resolution (6.15 Hz, 0.049 ppm) be detected (see supporting 357 
information).  358 
 359 
 360 
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Table 2. Determination of chiral discrimination of seven racemic tetrabutylammonium carboxylate salts in the presence 2c, using 361 
1H NMR (500 MHz, CDCl3, 27 °C) spectroscopy. 362 
Compd. [N4444]+ salt of racemic carboxylic acid  
 
ppm Hz 
7 
 
Me 0.000 0.0 
CHMe2 0.0096 4.8 
H 0.0087 4.4 
CH2 0.006 3.0 
     
8 
Me 0.0065 3.2 
H 0.0047 2.3 
     
9 H 0.0077 3.9 
     
10 
Me 0.000 0.0 
H 0.0055 2.8 
     
11 
Me 0.041 20.6 
H 0.000 0.0 
NH 0.019 9.7 
     
12 
Me 0.0021 1.1 
H 0.0033 1.6 
     
13 
 
H 0.0044 2.19 
 363 
Conclusions 364 
New (+)-dehydroabietylimidazolium chiral solvating agents were synthesised and tested for the resolution of Mosher’s acid (5) 365 
and its tetrabutylammonium salt (6). All nine cationic chiral solvating agents resolved 6 highly efficiently. The best resolution of 366 
the enantiomers of 6 was obtained with 2c. The enantiomers of 5 were also resolved and gave better resolution in 1H NMR spectra 367 
compared to 6, which was better resolved in 19F NMR spectra.  The behaviour of 6 in resolution was further studied by titration, 368 
which indicated a 1:1 complexation between the host and guest. Further studies also showed that cationic chiral solvating agents 369 
such as 2c can be expediently used for the determination of enantiomeric excesses of other chiral racemic carboxylates. The 370 
enantiomeric resolution of seven racemic -substituted carboxylic acids was carried out with 2c, showing that acids containing 371 
polar group(s) at the -site can be resolved efficiently. Additionally, there is no strict requirement for the presence of an aryl 372 
substituent in the carboxylic acid, allowing a wider diversity of the guest substrates. The new (+)-dehydroabietylimidazolium 373 
chiral solvating agents constitute a biorenewable approach to ee determination.  374 
Supplementary material 375 
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Spectral data of 1H and 13C NMR spectra and other spectra of synthesised products 1a-4c are available on the Journal’s website. 376 
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